| Lead Manager/ | # of | Price Range | Dollar | SCOOP | ||
| New Filings (Proposed Symbol) | Joint-Lead Managers | Shares | Low | High | Volume | Ratings |
| Agile Therapeutics (AGRX) | RBC Capital Markets/ William Blair & Company | $69.00 | n.a. | |||
| Alder BioPharmaceuticals (ALDR) | Credit Suisse/ Leerink Partners | $115.00 | n.a. | |||
| GlobeImmune (GBIM) | Aegis Capital Corp. | $35.00 | n.a. | |||
| Presbia PLC (LENS) | Jefferies | $90.00 | n.a. | |||
| Signal Genetics (SGNL) | Aegis Capital Corp | 2.27 | $10.00 | $12.00 | $24.99 | n.a. |
| Tarena International (TEDU) | Goldman Sachs (Asia)/ Credit Suisse | 15.30 | $8.00 | $10.00 | $137.70 | n.a. |
| n.a. (not available) | ||||||
| Postponed | ||||||
| None | ||||||
| Withdrawn | ||||||
| Devon Midstream Partners, L.P. (DVNM) | BofA Merrill Lynch/ Barclays | $400.00 | n.a. | |||
| Globoforce Ltd (THNX) | J.P. Morgan/ Credit Suisse/ UBS Investment Bank/ Stifel | 4.41 | $16.00 | $18.00 | $75.00 | 2-Stars |
| New Terms | ||||||
| 2U, Inc. (TWOU) | Goldman Sachs/ Credit Suisse | 9.18 | $11.00 | $13.00 | $110.10 | 3-Stars |
| Aerohive Networks (HIVE) | Goldman Sachs/ BofA Merrill Lynch | 7.50 | $9.00 | $11.00 | $75.00 | 3-Stars |
| Aldeyra Therapeutics (ALDX) | Aegis Capital Corp | 2.28 | $10.00 | $12.00 | $25.03 | n.a. |
| CBS Outdoor Americas (CBSO) | Goldman Sachs/ BofA Merrill Lynch/ J.P. Morgan/ Morgan Stanley | 20.00 | $26.00 | $28.00 | $540.00 | 2-Stars |
| Energous (WATT) | MDB Capital Group, LLC | 4.00 | $6.00 | $6.00 | $24.00 | n.a. |
| Everyday Health (EVDY) | J.P. Morgan/ Credit Suisse/ Citigroup | 7.15 | $13.00 | $15.00 | $100.10 | 2-Stars |
| Rubicon Project (The) (RUBI) | Morgan Stanley/ Goldman Sachs/ RBC Capital Markets, LLC | 6.77 | $15.00 | $17.00 | $108.34 | 3-Stars |
| SCYNEXIS (SCYX) | RBC Capital Markets/ Canaccord Genuity | 4.23 | $12.00 | $14.00 | $55.00 | n.a. |
| SunEdison Semiconductor (SEMI) | Deutsche Bank Securities/ Goldman Sachs/ Wells Fargo Securities | $250.00 | n.a. | |||
| Versartis (VSAR) | Morgan Stanley/ Citigroup | 6.00 | $19.00 | $21.00 | $120.00 | 3-Stars |
| IPOs Priced | Lead | Shares | Amount | Offer | Close | % |
| Week of March 17, 2014 | Manager(s) | Offered | Raised | Price | 3/21/14 | Change |
| Paylocity Holding (PCTY) | Deutsche Bank Securities/ BofA Merrill Lynch/ William Blair | 7.05 | $119.77 | $17.00 | $26.01 | 53.00% |
| Versartis (VSAR) | Morgan Stanley/ Citigroup | 6.00 | $126.00 | $21.00 | $31.37 | 49.38% |
| Akebia Therapeutics (AKBA) | Morgan Stanley/ Credit Suisse/ UBS Investment Bank | 5.88 | $100.00 | $17.00 | $23.70 | 39.41% |
| Amber Road (AMBR) | Stifel | 7.39 | $96.09 | $13.00 | $17.00 | 30.77% |
| MediWound Ltd. (MDWD) | Credit Suisse/ Jefferies/ BMO Capital Markets | 5.00 | $70.00 | $14.00 | $18.16 | 29.71% |
| Borderfree (BRDR) | Credit Suisse/ RBC Capital Markets/ Pacific Crest Securities | 5.00 | $80.00 | $16.00 | $20.00 | 25.00% |
| Q2 Holdings (QTWO) | J.P. Morgan/ Stifel | 7.76 | $100.89 | $13.00 | $16.13 | 24.08% |
| A10 Networks (ATEN) | Morgan Stanley/ BofA Merrill Lynch/ J.P. Morgan Securities/ RBC Capital Markets | 12.50 | $187.50 | $15.00 | $16.21 | 8.07% |
| Ruthigen (RTGN) (u) | Dawson James Securities | 2.65 | $19.21 | $7.25 | $7.25 | 0.00% |
| TPG Specialty Lending (TSLX) | J.P. Morgan/ BofA Merrill Lynch/ Goldman Sachs/ Citigroup/ Wells Fargo Securities/ Barclays | 7.00 | $112.00 | $16.00 | $16.00 | 0.00% |
